Our High Quality (HQ) offering adopts features of Cobra’s GMP manufacture with a 6 week delivery time. HQ plasmid can be used as an ancillary or starting material for the clinical manufacture of immuno-oncology therapies, for example in AAV, lentiviral vector and CRISPR products.
Current standard offerings for HQ supply are from 50mg to 500mg of purified plasmid; this can be tailored to meet specific customer requirements.
HQ production is performed in a Class 2 segregated laboratory using HQ production cell banks as starting material. The HQ grade plasmids are released with a Certificate of Testing and QA TSE Certification.
As an specialised Gene Therapy CDMO, with almost 20 years experience in the field, Cobra can provide a seamless service right through to clinical supply including fill finish. In terms of timelines, we aim for a production cell bank within two weeks and then just four weeks to plasmid.
Get In Touch
Speak to a member of our expert team and arrange to take a tour of our GMP facilities in the UK and Sweden